Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress

Sekyung Oh1,2, Ryan A Flynn3, Stephen N Floor4

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.

Oncotarget
|April 9, 2016
PubMed

Insights

The DEAD-box helicase DDX3X protein binds RNA and translation machinery, impacting medulloblastoma. Cancer-associated variants alter stress responses, selectively preserving translation of key genes.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • DDX3X mutations are common in medulloblastoma.
  • The precise role of DDX3X in RNA metabolism and translation is unclear.
  • Understanding DDX3X function is crucial for medulloblastoma research.

Purpose of the Study:

  • To elucidate the RNA-binding and functional interactions of DDX3X.
  • To investigate DDX3X's role in translation initiation and stress response.
  • To analyze the impact of medulloblastoma-associated DDX3X variants on cellular processes.

Main Methods:

  • RNA immunoprecipitation (RIP) followed by sequencing.
  • Analysis of translation initiation complex components.
  • Characterization of DDX3X variants (DDX3R534H) in cellular models.
  • Assessment of mRNA translation under stress conditions (arsenite).

Main Results:

  • DDX3X directly binds 5'UTRs of coding RNAs, 18S rRNA, and translation initiation factors.
  • Medulloblastoma samples with DDX3X mutations show impaired translation initiation.
  • Arsenite stress causes DDX3X to shift binding from 5'UTR to coding regions, reducing global translation.
  • The DDX3R534H variant blunts this stress-induced shift and preserves translation of chromatin organization genes.

Conclusions:

  • DDX3X is a key regulator of translation initiation and the cellular stress response.
  • Medulloblastoma-associated DDX3X variants exhibit altered stress response mechanisms.
  • DDX3X variants can selectively maintain translation of specific gene sets under stress, potentially contributing to tumorigenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
21.8K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
159.6K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.3K